HP
DGX icon

HealthInvest Partners’s Quest Diagnostics DGX Stock Holding History

HealthInvest Partners’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$2.81M Buy
+28,500
New +$2.7M 5.92% 4

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

HealthInvest Partners's DGX Position: Q4 2017 in Review

HealthInvest Partners opened a new position in Quest Diagnostics (DGX) in Q4 2017: 28,500 shares worth $2.81M. The stake represents 5.92% of the portfolio and ranks #4 among its holdings.

631 funds tracked by Wall St. Rank hold DGX as of Q4 2017.

  • HealthInvest Partners held 28,500 shares of Quest Diagnostics worth $2.81M as of Q4 2017.
  • Quest Diagnostics was a new HealthInvest Partners position in Q4 2017.
  • Quest Diagnostics made up 5.92% of HealthInvest Partners's portfolio in Q4 2017, its #4 holding.
  • 631 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2017.

Based on HealthInvest Partners's 13F filing for Q4 2017, filed 9 Feb 2018.